Stock Analysis: IHH Healthcare | Lianhe Zaobao
I'm PortAI, I can summarize articles.
IHH Healthcare recommends buying, with a target price of 2.61 MYR, and the current closing price is 2.10 MYR. Affected by rising financing costs, IHH Healthcare's net profit in the second quarter of this year fell by 9% year-on-year to 518 million MYR, but revenue increased by 7% year-on-year to 6.4 billion MYR, mainly due to the contribution from island hospitals in Malaysia. The Elizabeth Hospital in Singapore has completed renovations and is expected to return to normal utilization rates in the second quarter of next year. Maintains a "buy" rating
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zaobao The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments